Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Mok

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Research|November 17, 2007
Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virusWilson Mok, Yves Boucher, Rakesh K Jain
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapyWilson Mok, Triantafyllos Stylianopoulos, Yves Boucher, et al.
F1000Research|November 19, 2019
Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance's 2018 Vaccine Investment Strategy: report from an expert surveyMaya Malarski, Mateusz Hasso-Agopsowicz, Adam Soble, et al.
Health Affairs (Project Hope)|February 10, 2016
Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization ProgramsJudith Kallenberg, Wilson Mok, Robert Newman, et al.
Pediatric Pulmonology|February 6, 2020
A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthmaCindy L J Weinstein, Davis Gates, Xiaoli Zhang, et al.
Biophysical Journal|July 8, 2009
Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivoVikash P Chauhan, Ryan M Lanning, Benjamin Diop-Frimpong, et al.
Cancer Research|March 3, 2006
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vectorTrevor D McKee, Paola Grandi, Wilson Mok, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Research|November 17, 2007
Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virusWilson Mok, Yves Boucher, Rakesh K Jain
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapyWilson Mok, Triantafyllos Stylianopoulos, Yves Boucher, et al.
F1000Research|November 19, 2019
Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance's 2018 Vaccine Investment Strategy: report from an expert surveyMaya Malarski, Mateusz Hasso-Agopsowicz, Adam Soble, et al.
Health Affairs (Project Hope)|February 10, 2016
Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization ProgramsJudith Kallenberg, Wilson Mok, Robert Newman, et al.
Pediatric Pulmonology|February 6, 2020
A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthmaCindy L J Weinstein, Davis Gates, Xiaoli Zhang, et al.
Biophysical Journal|July 8, 2009
Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivoVikash P Chauhan, Ryan M Lanning, Benjamin Diop-Frimpong, et al.
Cancer Research|March 3, 2006
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vectorTrevor D McKee, Paola Grandi, Wilson Mok, et al.
Pageof 1